"
Team:Uppsala/chassi-group
From 2013.igem.org
(Difference between revisions)
| (6 intermediate revisions not shown) | |||
| Line 13: | Line 13: | ||
</style> | </style> | ||
| + | |||
| + | <script type="text/javascript"> | ||
| + | /*Acts once the document is loaded*/ $(document).ready(function() { /*Move the tn-main-wrap as child of <body>*/ $("#tn-main-wrap-wrap").prependTo($("body")); /*Move the menubars in the tn-main-wrap*/ $("#menubar.left-menu").appendTo($("#tn-main-wrap")); $("#menubar.right-menu").appendTo($("#tn-main-wrap")); | ||
| + | /*Spoiler JS*/ $(".tn-spoiler div").slideUp(); $(".tn-spoiler a").click(function(e) { e.preventDefault(); $(".tn-spoiler-active").removeClass("tn-spoiler-active"); $(this).parent().addClass("tn-spoiler-active"); $(".tn-spoiler").not(".tn-spoiler-active").children("div").slideUp(); $(".tn-spoiler-active").children("div").slideToggle(); }); | ||
| + | /*Add favicon*/ $("link[rel='shortcut icon']").remove(); $("head").append("<link rel='shortcut icon' type='image/png' href='https://static.igem.org/mediawiki/2013/6/6d/Uppsalas-cow-con.png'>"); }); | ||
| + | </script> | ||
</head> | </head> | ||
| Line 30: | Line 36: | ||
<div id="igem"><a href="https://2013.igem.org/Main_Page"><img class="igem" src="https://static.igem.org/mediawiki/2013/b/b8/Uppsala2013_Uppsala_IGEM_log_blue.png"></a></div> | <div id="igem"><a href="https://2013.igem.org/Main_Page"><img class="igem" src="https://static.igem.org/mediawiki/2013/b/b8/Uppsala2013_Uppsala_IGEM_log_blue.png"></a></div> | ||
| + | |||
| + | <img class="slogan" src="https://static.igem.org/mediawiki/2013/a/ad/Uppsala2013_Header.png"> | ||
</div> | </div> | ||
| Line 57: | Line 65: | ||
<li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a> | <li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a> | ||
<ul> | <ul> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid"> | + | <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid">p-Coumaric acid</a></li> |
<li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li> | ||
| Line 78: | Line 86: | ||
<li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a> | <li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a> | ||
<ul> | <ul> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/P-Coumaric-acid-pathway"> | + | <li><a href="https://2013.igem.org/Team:Uppsala/P-Coumaric-acid-pathway">Kinetic model</a></li> |
<li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li> | ||
| + | |||
| + | <li><a href="https://2013.igem.org/Team:Uppsala/toxicity-model">Toxicity model</a></li> | ||
</ul></li> | </ul></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li> | ||
| Line 88: | Line 98: | ||
<li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li> | ||
| + | <li><a href="https://2013.igem.org/Team:Uppsala/advisors">Advisors</a></li> | ||
</ul></li> | </ul></li> | ||
| Line 97: | Line 108: | ||
<li><a href="https://2013.igem.org/Team:Uppsala/public-opinion">Public opinion </a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/public-opinion">Public opinion </a></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/Outreach">High school & media </a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/Outreach">High school & media </a></li> | ||
| - | + | <li><a href="https://2013.igem.org/Team:Uppsala/bioart">BioArt</a></li> | |
| + | <li><a href="https://2013.igem.org/Team:Uppsala/LactonutritiousWorld">A LactoWorld</a></li> | ||
| + | <li><a href="https://2013.igem.org/Team:Uppsala/killswitches">Killswitches</a></li> | ||
| + | <li><a href="https://2013.igem.org/Team:Uppsala/realization">Patent</a></li> | ||
</ul></li> | </ul></li> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a | + | <li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a></li> |
| - | + | ||
| - | + | ||
| - | + | ||
<li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a> | <li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a> | ||
<ul> | <ul> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/safety-form">Safety form</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/safety-form">Safety form</a></li> | ||
| + | <li><a href="https://2013.igem.org/Team:Uppsala/protocols">Protocols</a></li> | ||
</ul></li> | </ul></li> | ||
</ul> | </ul> | ||
| Line 114: | Line 126: | ||
<div id="main_content"> <!-- Put content here --> | <div id="main_content"> <!-- Put content here --> | ||
| - | <h1>Chassi group</h1> | + | <h1 class="main-title">Chassi group</h1> |
| - | <img class="team-pic-template" src="https://static.igem.org/mediawiki/2013/ | + | <img class="team-pic-template" src="https://static.igem.org/mediawiki/2013/9/9b/Genet_9.jpg"> |
| Line 139: | Line 151: | ||
<h1 align="right">Stephanie Elizabeth Herman</h1> | <h1 align="right">Stephanie Elizabeth Herman</h1> | ||
<img class="right" src="https://static.igem.org/mediawiki/2013/8/8b/Steffani_port.jpg"> | <img class="right" src="https://static.igem.org/mediawiki/2013/8/8b/Steffani_port.jpg"> | ||
| - | <div id="text- | + | <div id="text-left"> |
<b>When/Why did your interest in bioengineering start?</b><br> | <b>When/Why did your interest in bioengineering start?</b><br> | ||
| - | -My interest in bioengineering began in my last year in high school. I got the chance to work at Stockholm University and explore how apoptosis works at tumor human nervcells. | + | -My interest in bioengineering began in my last year in high school. I got the chance to work at Stockholm University and explore how apoptosis works at tumor human nervcells. It wasn’t exactly bioengineering, but later on I discovered that there was a way to combine my interests in building stuff and cell biology, bioengineering! |
<br><br> | <br><br> | ||
<b>Does your primary interest lie in engineering or in biology/biotechnology?</b><br> | <b>Does your primary interest lie in engineering or in biology/biotechnology?</b><br> | ||
| Line 262: | Line 274: | ||
<div id="bottom-pic"> | <div id="bottom-pic"> | ||
| - | + | ||
</div> | </div> | ||
Latest revision as of 19:56, 27 October 2013
Chassi group
Anders Edlund
When/Why did your interest in bioengineering start?
-I have always been fascinated with life and biology. I started out studying economics but switched fields to biotechnology because I felt I had a stronger interest and I feel that there is a huge untapped potential today in this field.
Does your primary interest lie in engineering or in biology/biotechnology?
-Definately biotechnology.
Why did you choose to participate in iGEM?
-I participated last year and felt that I learned a lot and that it was fun. I felt that it would be a great experience to do it again. I also feel the synthetic biology approach is very interesting and promising and I wanted a chance to explore it further.
-I have always been fascinated with life and biology. I started out studying economics but switched fields to biotechnology because I felt I had a stronger interest and I feel that there is a huge untapped potential today in this field.
Does your primary interest lie in engineering or in biology/biotechnology?
-Definately biotechnology.
Why did you choose to participate in iGEM?
-I participated last year and felt that I learned a lot and that it was fun. I felt that it would be a great experience to do it again. I also feel the synthetic biology approach is very interesting and promising and I wanted a chance to explore it further.
Stephanie Elizabeth Herman
When/Why did your interest in bioengineering start?
-My interest in bioengineering began in my last year in high school. I got the chance to work at Stockholm University and explore how apoptosis works at tumor human nervcells. It wasn’t exactly bioengineering, but later on I discovered that there was a way to combine my interests in building stuff and cell biology, bioengineering!
Does your primary interest lie in engineering or in biology/biotechnology?
-Both
Why did you choose to participate in iGEM?
-I wanted to contribute to the growth in synthetic biology. Also I thought it was fun to finally do something outside of my studies.
-My interest in bioengineering began in my last year in high school. I got the chance to work at Stockholm University and explore how apoptosis works at tumor human nervcells. It wasn’t exactly bioengineering, but later on I discovered that there was a way to combine my interests in building stuff and cell biology, bioengineering!
Does your primary interest lie in engineering or in biology/biotechnology?
-Both
Why did you choose to participate in iGEM?
-I wanted to contribute to the growth in synthetic biology. Also I thought it was fun to finally do something outside of my studies.
Alona Nyberg
When/Why did your interest in bioengineering start?
-In early high school.
Does your primary interest lie in engineering or in biology/biotechnology?
-Both
Why did you choose to participate in iGEM?
-To gain valuable experience in fundamental laboratory work, as well as in working in a project environment. Of course, the social aspect of it also played a big part in my decision.
-In early high school.
Does your primary interest lie in engineering or in biology/biotechnology?
-Both
Why did you choose to participate in iGEM?
-To gain valuable experience in fundamental laboratory work, as well as in working in a project environment. Of course, the social aspect of it also played a big part in my decision.
Anton Berglund
When/Why did your interest in bioengineering start?
-I have always been interested in how nature and biology works.
Does your primary interest lie in engineering or in biology/biotechnology?
-Both
Why did you choose to participate in iGEM?
-I participated last year and had lots of fun. I wanted to use my experience from the previous year and try out the competition once more.
-I have always been interested in how nature and biology works.
Does your primary interest lie in engineering or in biology/biotechnology?
-Both
Why did you choose to participate in iGEM?
-I participated last year and had lots of fun. I wanted to use my experience from the previous year and try out the competition once more.
Mikael Strandgren
When/Why did your interest in bioengineering start?
-During the first weeks in X (The Molecular Biotechnology engineering program in Uppsala)
Does your primary interest lie in engineering or in biology/biotechnology?
-Both
Why did you choose to participate in iGEM?
-It seemed fun so I thought it would be nice to try!
-During the first weeks in X (The Molecular Biotechnology engineering program in Uppsala)
Does your primary interest lie in engineering or in biology/biotechnology?
-Both
Why did you choose to participate in iGEM?
-It seemed fun so I thought it would be nice to try!
Christoffer Ahlström
When/Why did your interest in bioengineering start?
-I started to consider going into something with bio- when i was around the age of 16. It seemed like a fun field with many undiscovered mysteries as well as much work left to do.
Does your primary interest lie in engineering or in biology/biotechnology?
-Both.
Why did you choose to participate in iGEM?
-I thought it sounded interesting and that it would be a good occupation during the summer. It is also similar to possible jobs in the future so it's a good idea to try it out.
-I started to consider going into something with bio- when i was around the age of 16. It seemed like a fun field with many undiscovered mysteries as well as much work left to do.
Does your primary interest lie in engineering or in biology/biotechnology?
-Both.
Why did you choose to participate in iGEM?
-I thought it sounded interesting and that it would be a good occupation during the summer. It is also similar to possible jobs in the future so it's a good idea to try it out.
Viktor Blomkvist
When/Why did your interest in bioengineering start?
-I have always been interested in biology, but it was not until I applied for the university my interest in biotech started.
Does your primary interest lie in engineering or in biology/biotechnology?
-Both.
Why did you choose to participate in iGEM?
-I thought it would be nice to get some more laboratory experience and my friends who participated last year recommended it.
-I have always been interested in biology, but it was not until I applied for the university my interest in biotech started.
Does your primary interest lie in engineering or in biology/biotechnology?
-Both.
Why did you choose to participate in iGEM?
-I thought it would be nice to get some more laboratory experience and my friends who participated last year recommended it.
Viktor Törnblom
When/Why did your interest in bioengineering start?
-I have always been interested in biology but my interest in bioengineering didn't start until I happened to come across bioengineering when applying to university.
Does your primary interest lie in engineering or in biology/biotechnology?
-Biology.
Why did you choose to participate in iGEM?
-I chose to participate in iGEM after hearing of a former iGEM-project that sought to decrease the desertification. The thought of students contributing to science this way was very intriguing to me.
-I have always been interested in biology but my interest in bioengineering didn't start until I happened to come across bioengineering when applying to university.
Does your primary interest lie in engineering or in biology/biotechnology?
-Biology.
Why did you choose to participate in iGEM?
-I chose to participate in iGEM after hearing of a former iGEM-project that sought to decrease the desertification. The thought of students contributing to science this way was very intriguing to me.
